Marine Drugs (Feb 2020)

Two New Alginate Lyases of PL7 and PL6 Families from Polysaccharide-Degrading Bacterium <i>Formosa algae</i> KMM 3553<sup>T</sup>: Structure, Properties, and Products Analysis

  • Alexey Belik,
  • Artem Silchenko,
  • Olesya Malyarenko,
  • Anton Rasin,
  • Marina Kiseleva,
  • Mikhail Kusaykin,
  • Svetlana Ermakova

DOI
https://doi.org/10.3390/md18020130
Journal volume & issue
Vol. 18, no. 2
p. 130

Abstract

Read online

A bifunctional alginate lyase (ALFA3) and mannuronate-specific alginate lyase (ALFA4) genes were found in the genome of polysaccharide-degrading marine bacterium Formosa algae KMM 3553T. They were classified to PL7 and PL6 polysaccharide lyases families and expressed in E. coli. The recombinant ALFA3 appeared to be active both on mannuronate- and guluronate-enriched alginates, as well as pure sodium mannuronate. For all substrates, optimum conditions were pH 6.0 and 35 °C; Km was 0.12 ± 0.01 mg/mL, and half-inactivation time was 30 min at 42 °C. Recombinant ALFA4 was active predominately on pure sodium mannuronate, with optimum pH 8.0 and temperature 30 °C, Km was 3.01 ± 0.05 mg/mL. It was stable up to 30 °C; half-inactivation time was 1 h 40 min at 37 °C. 1H NMR analysis showed that ALFA3 degraded mannuronate and mannuronate-guluronate blocks, while ALFA4 degraded only mannuronate blocks, producing mainly disaccharides. Products of digestion of pure sodium mannuronate by ALFA3 at 200 µg/mL inhibited anchorage-independent colony formation of human melanoma cells SK-MEL-5, SK-MEL-28, and RPMI-7951 up to 17% stronger compared to native polymannuronate. This fact supports previous data and suggests that mannuronate oligosaccharides may be useful for synergic tumor therapy.

Keywords